139 related articles for article (PubMed ID: 31521960)
1. Peripheral neuropathy in HIV patients on antiretroviral therapy: Does it impact function?
Dudley MT; Borkum M; Basera W; Wearne N; Heckmann JM
J Neurol Sci; 2019 Nov; 406():116451. PubMed ID: 31521960
[TBL] [Abstract][Full Text] [Related]
2. HIV neuropathy in South Africans: frequency, characteristics, and risk factors.
Maritz J; Benatar M; Dave JA; Harrison TB; Badri M; Levitt NS; Heckmann JM
Muscle Nerve; 2010 May; 41(5):599-606. PubMed ID: 20229576
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the prevalence of distal symmetrical polyneuropathy and its risk factors among HAART-treated and untreated HIV infected individuals.
Shurie JS; Deribew A
Ethiop Med J; 2010 Apr; 48(2):85-93. PubMed ID: 20608012
[TBL] [Abstract][Full Text] [Related]
4. Quality of life and self-reported lower extremity function in adults with HIV-related distal sensory polyneuropathy.
Galantino ML; Kietrys DM; Parrott JS; Stevens ME; Stevens AM; Condoluci DV
Phys Ther; 2014 Oct; 94(10):1455-66. PubMed ID: 24853912
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team.
Simpson DM; Katzenstein DA; Hughes MD; Hammer SM; Williamson DL; Jiang Q; Pi JT
AIDS; 1998 Dec; 12(18):2425-32. PubMed ID: 9875580
[TBL] [Abstract][Full Text] [Related]
6. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
Morgello S; Estanislao L; Simpson D; Geraci A; DiRocco A; Gerits P; Ryan E; Yakoushina T; Khan S; Mahboob R; Naseer M; Dorfman D; Sharp V;
Arch Neurol; 2004 Apr; 61(4):546-51. PubMed ID: 15096404
[TBL] [Abstract][Full Text] [Related]
7. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of HIV-associated neuropathy.
Gonzalez-Duarte A; Robinson-Papp J; Simpson DM
Neurol Clin; 2008 Aug; 26(3):821-32, x. PubMed ID: 18657728
[TBL] [Abstract][Full Text] [Related]
9. Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy.
Robinson-Papp J; Sharma S; Simpson DM; Morgello S
J Neurovirol; 2013 Apr; 19(2):172-80. PubMed ID: 23580249
[TBL] [Abstract][Full Text] [Related]
10. Elevated Biomarkers of Inflammation and Vascular Dysfunction Are Associated with Distal Sensory Polyneuropathy in People with HIV.
Andalibi MS; Fields JA; Iudicello JE; Diaz MM; Tang B; Letendre SL; Ellis RJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673830
[TBL] [Abstract][Full Text] [Related]
11. Clinical assessment of peripheral neuropathy in HIV-infected children on antiretroviral therapy in rural South Africa.
Peters RP; Van Ramshorst MS; Struthers HE; McIntyre JA
Eur J Pediatr; 2014 Sep; 173(9):1245-8. PubMed ID: 24691679
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of distal sensory polyneuropathy in antiretroviral-treated and untreated people with HIV in Tanzania.
Mullin S; Temu A; Kalluvya S; Grant A; Manji H
Trop Med Int Health; 2011 Oct; 16(10):1291-6. PubMed ID: 21707880
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of sensory neuropathy in HIV patients treated with tenofovir: A 6-month follow-up study.
Pillay P; Wadley AL; Cherry CL; Karstaedt AS; Kamerman PR
J Peripher Nerv Syst; 2019 Dec; 24(4):304-313. PubMed ID: 31587421
[TBL] [Abstract][Full Text] [Related]
14. HIV neuropathy natural history cohort study: assessment measures and risk factors.
Simpson DM; Kitch D; Evans SR; McArthur JC; Asmuth DM; Cohen B; Goodkin K; Gerschenson M; So Y; Marra CM; Diaz-Arrastia R; Shriver S; Millar L; Clifford DB;
Neurology; 2006 Jun; 66(11):1679-87. PubMed ID: 16769940
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda.
Tumusiime DK; Venter F; Musenge E; Stewart A
BMC Public Health; 2014 Dec; 14():1306. PubMed ID: 25526665
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.
Kvalsund M; Chidumayo T; Hamel J; Herrmann D; Heimburger D; Peltier A; Birbeck G
J Neurol Sci; 2018 May; 388():61-69. PubMed ID: 29627032
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in HIV: prevalence and risk factors.
Evans SR; Ellis RJ; Chen H; Yeh TM; Lee AJ; Schifitto G; Wu K; Bosch RJ; McArthur JC; Simpson DM; Clifford DB
AIDS; 2011 Apr; 25(7):919-28. PubMed ID: 21330902
[TBL] [Abstract][Full Text] [Related]
18. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy.
Hart AM; Wilson AD; Montovani C; Smith C; Johnson M; Terenghi G; Youle M
AIDS; 2004 Jul; 18(11):1549-60. PubMed ID: 15238773
[TBL] [Abstract][Full Text] [Related]
19. Understanding the etiology and management of HIV-associated peripheral neuropathy.
Stavros K; Simpson DM
Curr HIV/AIDS Rep; 2014 Sep; 11(3):195-201. PubMed ID: 24969360
[TBL] [Abstract][Full Text] [Related]
20. Managing HIV peripheral neuropathy.
Gonzalez-Duarte A; Cikurel K; Simpson DM
Curr HIV/AIDS Rep; 2007 Aug; 4(3):114-8. PubMed ID: 17883996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
